Naufal Zagidullin

Prof. Naufal Zagidullin

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2018 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
XGXiaofei Guo
Xiaofei Guo
YBYan Bai
Yan Bai
LZLi Zhang
Li Zhang
BZBo Zhang
Bo Zhang
NZNaufal Zagidullin
Naufal Zagidullin
BCBenzhi Cai
Benzhi Cai
In the past years, cardiac mortality has decreased, but cardiac diseases are still responsible for millions of deaths every year worldwide. Bone-marrow mesenchymal stem cells (BMSCs) transplantation may be a promising therapeutic strategy because of its capacity to differentiate into cardiac cells. Current research indicates that chemical substances, microRNAs, and cytokines have biological functions that regulate the cardiomyocytes differentiation of BMSCs. In this review, we chiefly summarize the regulatory factors that induce BMSCs to differentiate into cardiomyocytes.

2 September 2004 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
NGNatig Gassanov
Natig Gassanov
FEFikret Er
Fikret Er
NZNaufal Zagidullin
Naufal Zagidullin
UHUta C. Hoppe
Uta C. Hoppe

1 April 2019 in Gene
Verified
Journal Article
Closed access
GKGulnaz Faritovna Korytina
Gulnaz Faritovna Korytina
LALeysan Z. Akhmadishina
Leysan Z. Akhmadishina
YAYulia Aznabaeva
Yulia Aznabaeva
OKOlga V. Kochetova
Olga V. Kochetova
NZNaufal Zagidullin
Naufal Zagidullin
TVTatyana V. Viktorova
Tatyana V. Viktorova

1 November 2008 in Differentiation
Verified
Journal Article
Closed access
NGNatig Gassanov
Natig Gassanov
FEFikret Er
Fikret Er
NZNaufal Zagidullin
Naufal Zagidullin
MJMarek Jankowski
Marek Jankowski
JGJolanta Gutkowska
Jolanta Gutkowska
UHUta C. Hoppe
Uta C. Hoppe

24 January 2008 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
GMGuido Michels
Guido Michels
MBMathias C. Brandt
Mathias C. Brandt
NZNaufal Zagidullin
Naufal Zagidullin
IKIsmail F. Khan
Ismail F. Khan
RLRobert Larbig
Robert Larbig
UHUta C. Hoppe
Uta C. Hoppe
The hyperpolarization-activated cyclic nucleotide-gated (HCN) current If/IHCN is generally thought to be carried by Na+ and K+ under physiological conditions. Recently, Ca2+ influx through HCN channels has indirectly been postulated. However, direct functional evidence of Ca2+ permeation through If/IHCN is still lacking. To possibly provide direct evidence of Ca2+ influx through IHCN/If, we performed inside-out and cell-attached single-channel recordings of heterologously expressed HCN channels and native rat and human If, since Ca2+-mediated If/IHCN currents may not readily be recorded using the whole-cell technique. Original current traces demonstrated HCN2 Ca2+ inward currents upon hyperpolarization with a single-channel amplitude of −0.87 ± 0.06 pA, a low open probability of 3.02 ± 0.48% (at −110 mV, n = 6, Ca2+ 2 mmol/L), and a Ca2+ conductance of 8.9 ± 1.2 pS. IHCN2-Ca2+ was significantly activated by the addition of cAMP with an increase in the open probability and suppressed by the specific If inhibitor ivabradine, clearly confirming that Ca2+ influx indeed was conducted by HCN2 channels. Changing [Na+] (10 vs. 100 mmol/L) in the presence or absence of 2 mmol/L Ca2+ caused a simple shift of the reversal potential along the voltage axis without significantly affecting Na+/Ca2+ conductance, whereas the K+ conductance of HCN2 increased significantly in the absence of external Ca2+ with increasing K+ concentrations. The mixed K+–Ca2+ conductance, however, was unaffected by the external K+ concentration. Notably, we could also record hyperpolarization-activated Ca2+ permeation of single native If channels in neonatal rat ventriculocytes and human atrial myocytes in the presence of blockers for all known cardiac calcium conduction pores (Ca2+ conductance of human If, 9.19 ± 0.34 pS; amplitude, −0.81 ± 0.01 pA; open probability, 1.05 ± 0.61% at −90 mV). We directly show Ca2+ permeability of native rat and, more importantly, human If at physiological extracellular Ca2+ concentrations at the physiological resting membrane potential. This might have particular implications in diseased states with increased If density and HCN expression.

18 February 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NZNaufal Zagidullin
Naufal Zagidullin
LMLukas J. Motloch
Lukas J. Motloch
DGDiana Gareeva
Diana Gareeva
AHAysilu Hamitova
Aysilu Hamitova
ILIrina Lakman
Irina Lakman
VPValentin Nikolaevich Pavlov
Valentin Nikolaevich Pavlov
ST-elevation myocardial infarction (STEMI) is one of the main reasons for morbidity and mortality worldwide. In addition to the classic biomarker NT-proBNP, new biomarkers like ST2 and Pentraxin-3 (Ptx-3) have emerged as potential tools in stratifying risk in cardiac patients. Indeed, multimarker approaches to estimate prognosis of STEMI patients have been proposed and their potential clinical impact requires investigation. In our study, in 147 patients with STEMI, NT-proBNP as well as serum levels of ST2 and Ptx-3 were evaluated. During two-year follow-up (FU; 734.2 ± 61.2 d) results were correlated with risk for cardiovascular mortality (CV-mortality). NT-proBNP (HR = 1.64, 95% CI = 1.21–2.21, p = 0.001) but also ST2 (HR = 1.000022, 95% CI = 1.00–1.001, p < 0.001) were shown to be reliable predictors of CV-mortality, while the highest predictive power was observed with Ptx-3 (HR = 3.1, 95% CI = 1.63–5.39, p < 0.001). When two biomarkers were combined in a multivariate Cox regression model, relevant improvement of risk assessment was only observed with NT-proBNP+Ptx-3 (AIC = 209, BIC = 214, p = 0.001, MER = 0.75, MEV = 0.64). However, the highest accuracy was seen using a three-marker approach (NT-proBNP + ST2 + Ptx-3: AIC = 208, BIC = 214, p < 0.001, MER = 0.77, MEV = 0.66). In conclusion, after STEMI, ST2 and Ptx-3 in addition to NT-proBNP were associated with the incidence of CV-mortality, with multimarker approaches enhancing the accuracy of prediction of CV-mortality.